ArticleThe Lancet. Infectious diseases2018

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.

Issaka Sagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.